Morgan Stanley Maintains Overweight on Sempra, Lowers Price Target to $104
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice TargetHot
Morgan Stanley analyst David Arcaro maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $108 to $104.
Morgan Stanley analyst David Arcaro maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $108 to $104.